116
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population

, ORCID Icon, , , & ORCID Icon
Pages 1-11 | Received 24 May 2017, Accepted 06 Oct 2017, Published online: 27 Dec 2018

References

  • Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global Cancer Statistics. CA Cancer J. Clin. 2011, 61, 69–90.
  • Hsing, A. W.; Devesa, S. S. Trends and Patterns of Prostate Cancer: What Do They Suggest? Epidemiol. Rev. 2001, 23, 3–13.
  • Ntais, C.; Polycarpou, A.; Tsatsoulis, A. Molecular Epidemiology of Prostate Cancer: androgens and Polymorphisms in Androgen-Related Genes. Eur. J. Endocrinol. 2003, 149, 469–477.
  • Chokkalingam, A. P.; Stanczyk, F. Z.; Reichardt, J. K.; Hsing, A. W. Molecular Epidemiology of Prostate Cancer: Hormone-Related Genetic Loci. Front. Biosci. 2007, 12, 3436–3460.
  • Zhou, X.; Wei, L.; Jiao, G.; Gao, W.; Ying, M.; Wang, N.; Wang, Y.; Liu, C. The Association between the APE1 Asp148Glu Polymorphism and Prostate Cancer Susceptibility: A Meta-Analysis Based on Case-Control Studies. Mol. Genet. Genomics. 2015, 290, 281–288.
  • Bratt, O. Hereditary Prostate Cancer: Clinical Aspects. J. Urol. 2002, 168, 906–913.
  • Huang, Q.; Whitington, T.; Gao, P.; Lindberg, J. F.; Yang, Y.; Sun, J.; Vaisanen, M. R.; Szulkin, R.; Annala, M.; Yan, J. A Prostate Cancer Susceptibility Allele at 6q22 Increases RFX6 Expression by Modulating HOXB13 Chromatin Binding. Nat. Genet. 2014, 46, 126–135.
  • Hazelett, D. J.; Rhie, S. K.; Gaddis, M.; Yan, C.; Lakeland, D. L.; Coetzee, S. G.; Henderson, B. E.; Noushmehr, H.; Cozen, W.; Kote-Jarai, Z.; et al. Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci. PLoS Genet. 2014, 10, e1004102
  • Spisak, S.; Lawrenson, K.; Fu, Y.; Csabai, I.; Cottman, R. T.; Seo, J. H.; Haiman, C.; Han, Y.; Lenci, R.; Li, Q.; et al. CAUSEL: An Epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants. Nat. Med. 2015, 21, 1357–1363.
  • Chen, H.; Yu, H.; Wang, J.; Zhang, Z.; Gao, Z.; Chen, Z.; Lu, Y.; Liu, W.; Jiang, D.; Zheng, S. L.; et al. Systematic Enrichment Analysis of Potentially Functional Regions for 103 Prostate Cancer Risk-Associated Loci. Prostate. 2015, 75, 1264–1276.
  • Rinn, J. L.; Chang, H. Y. Genome Regulation by Long Noncoding RNAs. Annu. Rev. Biochem. 2012, 81, 145–166.
  • Consortium, E. P.; Birney, E.; Stamatoyannopoulos, J. A.; Dutta, A.; Guigo, R.; Gingeras, T. R.; Margulies, E. H.; Weng, Z.; Snyder, M.; Dermitzakis, E. T.; et al. Identification and Analysis of Functional Elements in 1% of the Human Genome by the ENCODE Pilot Project. Nature. 2007, 447, 799–816.
  • Guttman, M.; Rinn, J. L. Modular Regulatory Principles of Large Non-Coding RNAs. Nature. 2012, 482, 339–346.
  • Groß, S.; Immel, U.-D.; Klintschar, M.; Bartel, F. Germline Genetics of the p53 Pathway Affect Longevity in a Gender Specific Manner. CAS. 2014, 7, 91–100.
  • Kino, T.; Hurt, D. E.; Ichijo, T.; Nader, N.; Chrousos, G. P. Noncoding RNA gas5 is a Growth Arrest- and Starvation-Associated Repressor of the Glucocorticoid Receptor. Sci. Signal. 2010, 3, ra8.
  • Brannan, C. I.; Dees, E. C.; Ingram, R. S.; Tilghman, S. M. The Product of the H19 Gene May Function as an RNA. Mol. Cell. Biol. 1990, 10, 28–36.
  • Chen, B.; Yu, M.; Chang, Q.; Lu, Y.; Thakur, C.; Ma, D.; Yi, Z.; Chen, F. Mdig de-Represses H19 Large Intergenic Non-Coding RNA (lincRNA) by down-Regulating H3K9me3 and Heterochromatin. Oncotarget. 2013, 4, 1427–1437.
  • Ma, L.; Bajic, V. B.; Zhang, Z. On the Classification of Long Non-Coding RNAs. RNA Biol. 2013, 10, 925–933.
  • Fatica, A.; Bozzoni, I. Long Non-Coding RNAs: New Players in Cell Differentiation and Development. Nat. Rev. Genet. 2014, 15, 7–21.
  • Grote, P.; Herrmann, B. G. The Long Non-Coding RNA Fendrr Links Epigenetic Control Mechanisms to Gene Regulatory Networks in Mammalian Embryogenesis. RNA Biol. 2013, 10, 1579–1585.
  • Li, Z.; Rana, T. M. Decoding the Noncoding: Prospective of lncRNA-Mediated Innate Immune Regulation. RNA Biol. 2014, 11, 979–985.
  • Lin, R.; Maeda, S.; Liu, C.; Karin, M.; Edgington, T. S. A Large Noncoding RNA is a Marker for Murine Hepatocellular Carcinomas and a Spectrum of Human Carcinomas. Oncogene. 2007, 26, 851–858.
  • Pei, Z.; Du, X.; Song, Y.; Fan, L.; Li, F.; Gao, Y.; Wu, R.; Chen, Y.; Li, W.; Zhou, H. Down-Regulation of lncRNA CASC2 Promotes Cell Proliferation and Metastasis of Bladder Cancer by Activation of the Wnt/Beta-Catenin Signaling Pathway. Oncotarget. 2017, 8, 18145–18153.
  • Li, T.; Xu, C.; Cai, B.; Zhang, M.; Gao, F.; Gan, J. Expression and Clinicopathological Significance of the lncRNA HOXA11-AS in Colorectal Cancer. Oncol. Lett. 2016, 12, 4155–4160.
  • He, A.; Chen, Z.; Mei, H.; Liu, Y. Decreased Expression of LncRNA MIR31HG in Human Bladder Cancer. Cancer Biomark. 2016, 17, 231–236.
  • Pibouin, L.; Villaudy, J.; Ferbus, D.; Muleris, M.; Prosperi, M. T.; Remvikos, Y.; Goubin, G. Cloning of the mRNA of Overexpression in Colon Carcinoma-1: A Sequence Overexpressed in a Subset of Colon Carcinomas. Cancer Genet. Cytogenet. 2002, 133, 55–60.
  • Fu, X.; Ravindranath, L.; Tran, N.; Petrovics, G.; Srivastava, S. Regulation of Apoptosis by a Prostate-Specific and Prostate Cancer-Associated Noncoding Gene, PCGEM1. DNA Cell Biol. 2006, 25, 135–141.
  • Calin, G. A.; Liu, C. G.; Ferracin, M.; Hyslop, T.; Spizzo, R.; Sevignani, C.; Fabbri, M.; Cimmino, A.; Lee, E. J.; Wojcik, S. E.; et al. Ultraconserved Regions Encoding ncRNAs are Altered in Human Leukemias and Carcinomas. Cancer Cell. 2007, 12, 215–229.
  • Hsieh, C. L.; Oakley-Girvan, I.; Balise, R. R.; Halpern, J.; Gallagher, R. P.; Wu, A. H.; Kolonel, L. N.; O'Brien, L. E.; Lin, I. G.; Van Den Berg, D. J.; et al. A Genome Screen of Families with Multiple Cases of Prostate Cancer: Evidence of Genetic Heterogeneity. Am. J. Hum. Genet. 2001, 69, 148–158.
  • Wiklund, F.; Gillanders, E. M.; Albertus, J. A.; Bergh, A.; Damber, J. E.; Emanuelsson, M.; Freas-Lutz, D. L.; Gildea, D. E.; Goransson, I.; Jones, M. S.; et al. Genome-Wide Scan of Swedish Families with Hereditary Prostate Cancer: Suggestive Evidence of Linkage at 5q11.2 and 19p13.3. Prostate. 2003, 57, 290–297.
  • Jin, G.; Sun, J.; Isaacs, S. D.; Wiley, K. E.; Kim, S. T.; Chu, L. W.; Zhang, Z.; Zhao, H.; Zheng, S. L.; Isaacs, W. B.; et al. Human Polymorphisms at Long Non-Coding RNAs (lncRNAs) and Association with Prostate Cancer Risk. Carcinogenesis. 2011, 32, 1655–1659.
  • Cao, D. L.; Gu, C. Y.; Zhu, Y.; Dai, B.; Zhang, H. L.; Shi, G. H.; Shen, Y. J.; Zhu, Y. P.; Ma, C. G.; Xiao, W. J.; et al. Polymorphisms at Long Non-Coding RNAs and Prostate Cancer Risk in an Eastern Chinese Population. Prostate Cancer Prostatic Dis. 2014, 17, 315–319.
  • Nikolic, Z. Z.; Brajuskovic, G. N.; Pavicevic, D.; Kojic, A. S.; Vukotic, V. D.; Tomovic, S. M.; Cerovic, S. J.; Filipovic, V.; Misljenovic, D.; Romac, S. P. Assessment of Possible Association between rs3787016 and Prostate Cancer Risk in Serbian Population. Int. J. Clin. Exp. Med. 2013, 6, 57–66.
  • Kang, M.; Sang, Y.; Gu, H.; Zheng, L.; Wang, L.; Liu, C.; Shi, Y.; Shao, A.; Ding, G.; Chen, S.; et al. Long Noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 a/C Polymorphisms are Associated with Decreased Risk of Esophageal Cancer. Tumour Biol. 2015, 36, 6401–6408.
  • Hashemi, M.; Shahkar, G.; Simforoosh, N.; Basiri, A.; Ziaee, S. A.; Narouie, B.; Taheri, M. Association of Polymorphisms in PRKCI Gene and Risk of Prostate Cancer in a Sample of Iranian Population. Cell. Mol. Biol. (Noisy-le-Grand) 2015, 61, 16–21.
  • Hashemi, M.; Moradi, N.; Ziaee, S. A.; Narouie, B.; Soltani, M. H.; Rezaei, M.; Shahkar, G.; Taheri, M. Association between Single Nucleotide Polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and Prostate Cancer Risk in a Sample of Iranian Population. J. Adv. Res. 2016, 7, 491–498.
  • Hashemi, M.; Danesh, H.; Bizhani, F.; Narouie, B.; Sotoudeh, M.; Nouralizadeh, A.; Sharifiaghdas, F.; Bahari, G.; Taheri, M. Pri-miR-34b/c rs4938723 Polymorphism Increased the Risk of Prostate Cancer. Cancer Biomark. 2017, 18, 155–159.
  • Hashemi, M.; Hanafi Bojd, H.; Eskandari Nasab, E.; Bahari, A.; Hashemzehi, N. A.; Shafieipour, S.; Narouie, B.; Taheri, M.; Ghavami, S. Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms with Nonalcoholic Fatty Liver Disease. Hepat. Mon. 2013, 13, e9527.
  • Sole, X.; Guino, E.; Valls, J.; Iniesta, R.; Moreno, V. SNPStats: A Web Tool for the Analysis of Association Studies. Bioinformatics. 2006, 22, 1928–1929.
  • Wu, S. W.; Hao, Y. P.; Qui, J. H.; Zhang, D. B.; Yu, C. G.; Li, H. W. High Expression of Long Noncoding RNA CCAT2 Indicates Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and Invasion. Minerva Med. 2017, 108, 317–323.
  • Guo, J.; Ma, J.; Zhao, G.; Li, G.; Fu, Y.; Luo, Y.; Gui, R. Long Non-Coding RNA LINC0086 Functions as a Tumor Suppressor in Nasopharyngeal Carcinoma by Targeting miR-214. Oncol. Res. 2017, 25, 1189.
  • Liu, J. N.; Shangguan, Y. M. Long Non-Coding RNA CARLo-5 Upregulation Associates with Poor Prognosis in Patients Suffering Gastric Cancer. Eur. Rev. Med. Pharmacol. Sci. 2017, 21, 530–534.
  • Chu, H.; Chen, Y.; Yuan, Q.; Hua, Q.; Zhang, X.; Wang, M.; Tong, N.; Zhang, W.; Chen, J.; Zhang, Z. The HOTAIR, PRNCR1 and POLR2E Polymorphisms are Associated with Cancer Risk: A Meta-Analysis. Oncotarget. 2017, 8, 43271–43283.
  • Ponting, C. P.; Oliver, P. L.; Reik, W. Evolution and Functions of Long Noncoding RNAs. Cell. 2009, 136, 629–641.
  • Keller, C.; Buhler, M. Chromatin-Associated ncRNA Activities. Chromosome Res. 2013, 21, 627–641.
  • Luco, R. F.; Misteli, T. More than a Splicing Code: Integrating the Role of RNA, Chromatin and Non-Coding RNA in Alternative Splicing Regulation. Curr. Opin. Genet. Dev. 2011, 21, 366–372.
  • Pircher, A.; Gebetsberger, J.; Polacek, N. Ribosome-Associated ncRNAs: An Emerging Class of Translation Regulators. RNA. Biol. 2014, 11, 1335–1339.
  • Hannon, G. J. RNA Interference. Nature. 2002, 418, 244–251.
  • Lee, J. T. Epigenetic Regulation by Long Noncoding RNAs. Science. 2012, 338, 1435–1439.
  • Khalil, A. M.; Guttman, M.; Huarte, M.; Garber, M.; Raj, A.; Rivea Morales, D.; Thomas, K.; Presser, A.; Bernstein, B. E.; van Oudenaarden, A.; et al. Many Human Large Intergenic Noncoding RNAs Associate with Chromatin-Modifying Complexes and Affect Gene Expression. PNAS. 2009, 106, 11667–11672.
  • Mercer, T. R.; Dinger, M. E.; Sunkin, S. M.; Mehler, M. F.; Mattick, J. S. Specific Expression of Long Noncoding RNAs in the Mouse Brain. Proc. Natl. Acad. Sci. USA. 2008, 105, 716–721.
  • Geisler, S.; Coller, J. RNA in Unexpected Places: Long Non-Coding RNA Functions in Diverse Cellular Contexts. Nat. Rev. Mol. Cell Biol. 2013, 14, 699–712.
  • Spizzo, R.; Almeida, M. I.; Colombatti, A.; Calin, G. A. Long Non-Coding RNAs and Cancer: A New Frontier of Translational Research?. Oncogene. 2012, 31, 4577–4587.
  • Tsai, M. C.; Spitale, R. C.; Chang, H. Y. Long Intergenic Noncoding RNAs: New Links in Cancer Progression. Cancer. Res. 2011, 71, 3–7.
  • Heemers, H.; Maes, B.; Foufelle, F.; Heyns, W.; Verhoeven, G.; Swinnen, J. V. Androgens Stimulate Lipogenic Gene Expression in Prostate Cancer Cells by Activation of the Sterol Regulatory Element-Binding Protein Cleavage Activating Protein/Sterol Regulatory Element-Binding Protein Pathway. Mol. Endocrinol. 2001, 15, 1817–1828.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.